Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
This grant funds interventions addressing barriers to cancer screening in populations facing health disparities, aiming to improve access and outcomes through community collaborations.
Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS) | Expiration: January 8, 2027
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years. Typical R01 NIH award size and duration apply.
Summary: Funds clinical trials testing interventions to expand cancer screening and preventive services in populations experiencing health disparities, with a focus on multi-level, community-engaged approaches.
Key Information: Clinical trial required. Projects must address barriers at ≥2 levels (e.g., patient, clinician, setting, community). NIH-designated disparity populations only.
Description
This opportunity supports research to develop and test interventions that expand or improve cancer screening and preventive services among populations experiencing health disparities in the United States. The program specifically requires clinical trials (R01 mechanism) and seeks projects that address barriers and facilitators to screening and preventive care at two or more levels: patient, clinician, healthcare setting, and neighborhood/community.
Projects should include, but are not limited to, interventions that:
- Increase access to and uptake of evidence-based cancer screening and preventive services.
- Ensure timely follow-up of abnormal findings and referral to accessible care.
- Leverage collaborations with community partners and service providers (e.g., clinics, schools, community centers, pharmacies, workplaces, faith-based organizations).
- Address multi-level barriers such as transportation, insurance, provider practices, organizational systems, and community resources.
Applications must focus on NIH-designated populations that experience health disparities. Projects that do not prospectively test an intervention, do not focus on these populations, or are solely observational/qualitative are not responsive.
Participating NIH components include the Office of Disease Prevention (ODP), National Cancer Institute (NCI), National Institute of Dental and Craniofacial Research (NIDCR), National Institute on Minority Health and Health Disparities (NIMHD), and the Office of Research on Women's Health (ORWH).
